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Autism spectrum disorder (ASD) affects approximately 1:68 individuals and has incalculable burdens on affected individuals, their families, and health care systems. While the genetic contributions to idiopathic ASD are heterogeneous and largely unknown, the causal mutations for syndromic forms of ASD -including truncations and copy number variants -provide a genetic toehold with which to gain mechanistic insights [1] [2] [3] . Models of these syndromic disorders have been used to better characterize the molecular and physiological processes disrupted by these mutations 4 . Two fundamental questions remain -how biologically similar are the mouse models of syndromic forms of ASD, and how relevant are these mouse models to their human analogs? To address these questions, we performed integrative transcriptomic analyses of seven independent mouse models of three syndromic forms of ASD generated across five laboratories,
and assessed dysregulated genes and their pathways in human postmortem brain from patients with ASD and unaffected controls. These cross-species analyses converged on shared disruptions in myelination and axon development across both syndromic and idiopathic ASD, highlighting both the face validity of mouse models for these disorders and identifying novel convergent molecular phenotypes amendable to rescue with therapeutics.
We first assessed molecular convergence across five different mouse models of Pitt-Hopkins syndrome (PTHS), a rare form of ASD that results from diverse mutations in the transcription factor 4 (TCF4) gene, ranging from haploinsufficiency to dominant-negative. This syndromic disorder is characterized by developmental delay, failure to acquire language, motor learning deficits, and gastrointestinal abnormalities [5] [6] [7] . We generated RNA-seq data from prefrontal cortex (PFC) of a PTHS mouse line that shows heterozygous expression of a truncated TCF4 protein (Tcf4 +/tr ) 8 (see Methods). The Tcf4 +/tr mouse showed significant blunted expression of full-length Tcf4 transcript (p=0.02, Figure S1A , B) and protein (p=0.0009, Figure S1C , D) in the brain between embryonic day 16 and postnatal day 4 (E16, P4) and smaller difference in expression in adulthood (p>0.05, Figure S1A , B, D). A similar expression pattern was observed across the human lifespan 9 , suggesting there may be a critical period for the genesis of PTHS that is concordant with early cortical development, a critical causal period identified for other syndromic and idiopathic forms of human ASD 10, 11 . In addition to the Tcf4 +/tr PFC RNA-seq and published of Tcf4 +/tr hippocampal CA1 12 dataset, we further created and processed RNA-seq data from four additional mouse lines of heterozygous Tcf4 mutations or deletions: Tcf4 +/D574-579 ,
Tcf4
+/R579W , Actin-Cre::Tcf4 +/floxed and Nestin-Cre::Tcf4 +/floxed (see Methods) . Given that Tcf4 is developmentally regulated and plays a role in gene regulation, we assessed the effects of heterozygous Tcf4 mutations (Tcf4 +/mut ) on the mouse transcriptome from the prefrontal cortex, CA1 region of hippocampus, and hemi-brain at P1 and in adulthood (see Figure 1A for details).
Differential expression analysis of each Tcf4
+/mut mouse model by age showed more differentially expressed genes (DEGs) in the adult brain than in the P1 brain, with overall high concordance and replication rates across these varied models and tissue sources ( Figure 1D , S2, Table S1 ). Combined analysis across the RNA-seq data from these multiple models of PTHS ("mouse mega-analysis") revealed widespread transcriptional dysregulation in the adult mouse brain in Tcf4 +/mut versus wild-type (WT) ( Figure 1B , Table S2 ). Gene ontology (GO) analysis of the DEGs showed age-specific processes involved in Tcf4 +/mut ( Figure 1E , see Table S3 for full GO analysis) -genes upregulated in adult brains were enriched for processes including forebrain development, neuron projection, axon development, excitatory and inhibitory synapse, postsynaptic density, and transcription cofactor activity while those genes downregulated enriched for neuron ensheathment, myelination, and peptide binding. Cell type-specific analysis (CSEA) using expression levels from microarrays 13 (p=2E-26, Figure S3 ) and RNA-seq of purified mouse cell types 14 further implicated oligodendrocytes as the candidate cell type implicated in Tcf4 +/mut (Fisher p adj <0.05, Figure 2A ). For example, adult mouse lines across all
Tcf4
+/mut models showed oligodendrocyte enrichment at all developmental stages with the most significant enrichment found in myelinating oligodendrocytes, where more than 55% of cell type-specific genes were differentially expressed in our mega-analysis. We further applied cellular deconvolution to obtain the estimated proportion of each cell type and identified a significant increase in the proportions of neurons (p=0.035) and astrocytes (p=0.007), and significant decrease in the proportions of myelinating oligodendrocytes (and p=0.002) in adult
+/mut mice. From previous purified cell type-expression data 14 , we see that Tcf4 is moderately expressed in oligodendrocyte precursor cells and newly formed oligodendrocytes, but lowly expressed in myelinating oligodendrocytes, suggesting decreased Tcf4 expression in immature cell types may obstruct oligodendrocyte maturation ( Figure 2B ). To validate that these mature oligodendrocyte-specific RNA-seq signatures reflect functional deficits in our PTHS mouse models, we measured the expression of key oligodendrocyte proteins (CNP, MOG, and NG2)
from Tcf4 +/tr and WT adult brain lysates ( Figure 3D ). Relative protein levels of myelinating oligodendrocyte markers, CNP and MOG, were significantly decreased in Tcf4 +/tr mice ( Figure   3E , N=12 each, p MOG =0.0008, p CNp= 0.0436) and their fold-changes in mutant vs. WT mice correlated with fold-changes from the RNA-seq differential expression analysis ( Figure 3F ). However, the relative protein level and RNA-seq expression of NG2, the marker for oligodendrocyte precursor cells, was not different between genotypes (N=12, p=0.815).
Together, these data suggest that TCF4 is critical to the proper maturation of oligodendrocytes and the process of myelination but not in the development of oligodendrocyte precursor cells. Figure 3A ). The CAGs were strongly enriched for several myelination-related GO terms, showing up to 15% of the genes involved in some processes ( Figure 3D , p adj <0.0149). The CAGs are generally down-regulated in the Tcf4 mice while being up-regulated in Pten and Mecp2 mutations, which is consistent with prior studies demonstrating decreased PTEN and MeCP2 protein expression promote oligodendrocyte expansion and maturation 19, 20 (black-outlined points in Figure 3B- Figure 4C ). Specifically, we found the strongest enrichment of Tcf4 +/mut DEGs among human genes involved in myelination, axon ensheathment, and gliogenesis (asdM14, adjusted p=5.6e-22). In addition, we observed Tcf4
DEGs showed enrichment in other previously identified co-expression modules involved in synaptic transmission and mRNA processing ( Figure 4C ). Enrichment in these gene coexpression modules supports the idea that gene networks disrupted in Tcf4 +/mut are similar to gene networks disrupted in human ASD, and further identifies myelination as an additional pathway disrupted in ASD.
To better characterize phenotypes identified in mouse models with human illness, we directly compared RNA-seq data between Tcf4 +/mut mice and postmortem human brain tissue from ASD and 15q duplication postmortem brain from frontal cortex, temporal cortex, and cerebellar vermis 23 ( Figure S4A ). Differential expression between PTHS mouse and human ASD or 15q duplication was significantly concordant ( Figure S4B , p adj <0.05). Tcf4 +/mut DEGs strongly overlapped with human ASD and 15q duplication at replication p<0.05, displaying slightly more overlap with the 15q duplication diagnosis ( Figure S4C , p adj <0.05). Comparing replication of DEGs with a more stringent cutoff (p<0.01), gene regulation became more correlated with higher concordance rates, suggesting these groups of genes better represent the shared pathways affected in both PTHS and human ASD. GO analysis of DEGs in frontal and temporal cortex overlapping with PTHS mouse DEGs enriched for processes related to axon and dendrite projection development and postsynaptic regulation and signaling ( Figure S4E ). Lastly, we evaluated the ability of our mouse gene sets to distinguish patients with ASD and 15q duplication from unaffected individuals. We obtained only marginal separation of patients with ASD from controls among the 1718 human homologs of Tcf4 +/mut mouse DEGs (via the top eigengene, Figure 4A , p=0.022). However, we significantly separated both patients with ASD and 15q duplication from controls using the CAG set at similar magnitudes (via the top eigengene, Figure 4C , p ASD =1.5e-6, p 15qDup =0.0098). This top eigengene was directionally consistent between the human and mouse samples, such that decreasing expression of the convergent mouse gene set corresponded to decreased expression of oligodendrocyte genes in human patients with ASD.
By comparing differential expression in mouse models of Tcf4 +/mut mice with human ASD and 15q duplication, we observed similar trends in differential expression between the datasets, particularly among the CAGs. The observed positive correlation between altered gene regulation in mouse models of syndromic ASD with those in idiopathic human ASD strongly supports the hypothesis that defects in myelination are a common pathophysiology in syndromic and idiopathic ASD. This cross-species framework demonstrates the usefulness of mouse models to human ASD and highlights novel targets and pathways for potential pharmaceutical intervention.
MATERIALS AND METHODS

Animals and tissue collection
The Tcf4 +/tr mouse model of PTHS 6 were heterozygous for a deletion of the DNA-binding domain of the Transcription Factor 4(B6;129-TCF4tm1Zhu/J; stock number 013598, Jackson
Laboratory, Bar Harbor, ME) 8 . This deletion truncates the transcript after the first helix of the basic helix-loop-helix (bHLH) domain in exon 19 8 . This mouse colony was backcrossed 6
generations, maintained by SoBran on a 12-hour light cycle, and fed ad libitum. Tcf4 +/tr mouse samples were matched with WT littermates, and sex was randomly selected in each genotype and age group. The Tcf4 R579W and Tcf4 △574-579 were generated using Crispr/Cas9 technology by the Animals Models Core facility at UNC. Heterozygous founders from each mutation were checked for off-target effects of the guide RNA, to which no changes were found. 
qRT-PCR
To measure Tcf4 transcript expression across Tcf4 +/tr mouse lifespan in mouse, three cortical samples were collected each from both genotypes over 11 developmental ages from embryonic Lysates were mixed with 20% SDS (Amresco) for a final concentration of 2% and resonicated.
Lysates were then incubated on a rotator for 1hr in 4°C and centrifuged at 20,000g for 5 minutes at 4°C. Supernatants were quantified using BCA kit (Pierce).
Samples were blinded and randomly ordered on Western blots to control for batch bias. Total protein amounts of 20µg were used from each sample and separated using a 4-12% gradient Novex Bis-Tris Bolt SDS-PAGE gel via gel electrophoresis and transferred to 0.45 µm nitrocellulose membranes. Membranes were incubated at room temperature for 1hr in Odyssey PBS blocking buffer (Li-Cor), probed with anti-ITF-2 (N-16) (1:500, Santa Cruz) and anti-GAPDH (1:1000, Abcam) primary antibodies in Odyssey PBS blocking buffer overnight at 4⁰C, and detected using IRdye donkey anti-goat 680 (1:10,000, Li-Cor) and IRdye donkey anti-rabbit 800 (1:10,000, Li-Cor). Antibody detection and quantification was carried out using the LI-COR 
Comparison between differential expression analyses
Sub-analyses to determine DEGs within each mouse line and age group were similarly determined with DESeq2 with the linear model [geneCounts ~ Genotype + SVs] at alpha = 0.05.
Samples within these groups are considered balanced and matched. A DEG from one dataset is considered `replicated` if it is differentially expressed at p<0.05 in more than one dataset ( Figure   4 , 5, and S1).
Functional gene set analysis on the DEGs
We found enriched gene pathways in GO databases with the R-package clusterProfiler 27 . The clusterProfiler analysis tested the DEGs at p<0.01 from the pooled analysis in P1 and adult samples for over-represented gene sets using hypergeometric tests. DEGs are separated by positive and negative log 2 fold-change. We defined the background as the list of expressed genes with mean normalized counts > 1 and adjusted for multiple testing with q-value<0.05.
Cell type-specific expression and relative proportion analysis
We first used the CSEA approach 13 to determine cell type specificity of these TCF4 mutations, which are based on over-representation of cell type-specific genes, determined by TRAP.
Analyses and plots were generated with the online CSEA tool Independent validation of CSEA analysis took RNA-seq raw gene counts from purified cell types of mouse brain from Zhang et al. 14 and the CIBERSORT online tool (cibersort.stanford.edu) to create the set of signature genes using default parameters. The signature genes for enrichment was further limited to those upregulated in these cell types from DESeq2 analysis ( Figure 3A ). Raw gene counts from PTHS mice were passed to CIBERSORT to predict relative proportions of each cell type. Change in proportions of each cell type was determined by fitting the linear model `Proportion~ Genotype +Line`.
Comparing transcriptomes of multiple syndromic ASD mouse models
We compared DEGs from Tcf4 +/mut mice with two mouse models of ASD, MeCP2 knockout (Mecp2 KO ) 18 and homozygous Pten mutation (Pten m3m4/m3/m4 ) 16 . We processed the Mecp2 KO and Pten m3m4/m3/m4 RNA-seq datasets as described below and compared genes differentially expressed in our pooled TCF4 analysis to those also differentially expressed in MeCP2 and Pten homozygous mutations (FDR<0.05). We tested enrichment of differential expression, log 2 foldchange correlation, and log 2 fold-change directionality concordance with Fisher's Exact test and Spearman correlation test. We also report r, the Spearman's correlation coefficient, and 1-k, the rate of genes with opposite log 2 fold-change directionality. GO analysis for Figure 3D was performed on the set of genes differentially expressed in all three mouse models.
Comparing to human ASD risk genes, expression networks, and differential expression
To directly compare our PTHS mice models with sporadic human ASD, we compared our DEGs to the Simons Foundation Autism Research Initiative (SFARI) ASD risk gene database 28 and we searched for overlap using weighted gene co-expression network analyses (WGCNAs) from human ASD and neocortical development, as well as gene expression of a recent large RNA-seq study on human ASD postmortem brain 23 . We downloaded the list of ASD risk genes scored by SFARI by the evidence of their risk associations to idiopathic or syndromic ASD. We included 583 of the 632 risk genes that were homologous mice genes that are expressed in our RNA-seq dataset and used the Fisher's Exact test to test for over-representation of our DEGs in the list of human ASD risk genes. We tested enrichment with weighted gene co-expression network analysis (WGCNA) of human brain development 11 , microarray of human ASD 22 , and RNA-seq of human ASD 23 . For WGCNA data from the Voineagu et al. study, we assigned genes to the module that they have strongest membership (kME > 0.7). Here, we limited analysis to only expressed genes in the mouse data that have human homologs present in each WGCNA study.
As described in these papers, we tested enrichment in each co-expression module with two-tailed
Fisher's Exact test, included only positive enrichment (odds ratio > 1), and adjusted for multiple testing with the false discovery rate (FDR<0.05). We also provide a companion GO analysis of these enriched modules to interpret the molecular pathways involved in each co-expression networks. We used all genes in each module with the background as the list of genes reported in each study.
Comparing mouse models of PTHS with human ASD RNA-seq
Lastly, we compared adult PTHS DEGs with differential expression of human ASD vs. control in three brain regions (DLPFC, auditory cortex, and cerebellar vermis). We used biomaRt 29 to map mice genes to their human homolog genes and determined fold-change concordance with chi square test of independence in significant DEGs in both datasets (FDR<0.01 in mice, p<0.05
in human). We tested the log 2 fold-change correlation with Fisher's Exact tests. We report k, the rate of genes with concordant log 2 fold-change directionalities between PTHS mouse and human ASD or 15q duplication in each brain region with their respective permutation p-values of 1000
iterations. We subsequently performed GO analysis on genes in both mouse and human for each brain region (as above) with the background as the set of expressed genes with mouse homologs.
Other RNA-seq data processing: Samples come from 3 regions, medial prefrontal cortex, hemibrain, and hippocampal CA1
(colored red, black, and teal, respectively) 12 . Two age groups, P0-2 (P1) and >P42 (adult), were assessed in this study. N's of wild-type and PTHS mice are colored black and red, respectively. 
